Ping An Biomedical Co., Ltd. (PASW)
Consumer Cyclical · NCM
Fundamentals
Valuation and ratings
Ping An Biomedical Co., Ltd. trades at USD0.12, which is 133% below the USD0.27 our discounted cash flow model puts on the business. On that measure alone it screens as undervalued, though a DCF is an argument rather than a measurement, and the market is frequently right about why something is cheap.
Our moat model scores it 10 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
About Ping An Biomedical Co., Ltd.
Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finished garments; real estate property investment; and warehousing services. The company serves brand owners, textile manufacturers, apparel sourcing agents, and online fashion and garment retailers. It was formerly known as Majestic Ideal Holdings Ltd. and changed its name to Ping An Biomedical Co., Ltd. in September 2025. The company was founded in 2013 and is based in Cheung Sha Wan, Hong Kong. Ping An Biomedical Co., Ltd. operates as a subsidiary of Action Holdings Limited.
PASW passes 1 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Common questions
Is Ping An Biomedical Co., Ltd. (PASW) undervalued?
Against our discounted cash flow estimate of USD0.27, PASW at USD0.12 is 133% below fair value. That is one model's answer, not a recommendation, and most of a DCF's output sits in a terminal value nobody can forecast.
The full research page for PASW, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.